ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: It was shown that the upregulation of this pathway, triggered by the TGF–βinBCR–ABL1 positive hemangioblasts, leads to an enhanced secretion of soluble Kit ligand and ICAM1, promoting the activation and proliferation of CML stem cells [17,18].